JMVIX
Price
$16.46
Change
+$0.10 (+0.61%)
Updated
Oct 17 closing price
Net Assets
1.98B
JVMCX
Price
$27.55
Change
+$0.12 (+0.44%)
Updated
Oct 17 closing price
Net Assets
23.85B
Interact to see
Advertisement

JMVIX vs JVMCX

Header iconJMVIX vs JVMCX Comparison
Open Charts JMVIX vs JVMCXBanner chart's image
Janus Henderson Mid Cap Value S
Price$16.46
Change+$0.10 (+0.61%)
VolumeN/A
Net Assets1.98B
JHancock Disciplined Value Mid Cap C
Price$27.55
Change+$0.12 (+0.44%)
VolumeN/A
Net Assets23.85B
JMVIX vs JVMCX Comparison Chart in %
View a ticker or compare two or three
VS
JMVIX vs. JVMCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVIX is a Buy and JVMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.9B vs. JMVIX (1.98B). JMVIX pays higher dividends than JVMCX: JMVIX (0.35) vs JVMCX (0.00). JMVIX was incepted earlier than JVMCX: JMVIX (16 years) vs JVMCX (14 years). JVMCX (1.86) is less costly to investors than JMVIX (1.14). JVMCX is a more actively managed with annual turnover of: 49.00 vs. JMVIX (40.00). JVMCX has a lower initial minimum investment than JMVIX: JVMCX (1000) vs JMVIX (2500). JVMCX annual gain was more profitable for investors over the last year : -6.45 vs. JMVIX (-8.74). JVMCX return over 5 years is better than : 40.87 vs. JMVIX (17.67).
JMVIXJVMCXJMVIX / JVMCX
Total Expense Ratio1.141.8562%
Annual Report Gross Expense Ratio1.141.8661%
Fund Existence16 years14 years-
Gain YTD3.3928.89338%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.98B23.9B8%
Annual Yield % from dividends0.350.00-
Returns for 1 year-8.74-6.45136%
Returns for 3 years10.7921.6050%
Returns for 5 years17.6740.8743%
Returns for 10 years-11.1638.46-29%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRVCF0.02N/A
+3.76%
PreveCeutical Medical Inc.
IMIAF30.92N/A
N/A
IMI plc
SPNUF2.67N/A
N/A
Spirent Communications Plc
ATEYY114.55-1.20
-1.04%
Advantest Corp.
CVVUF0.64-0.03
-4.79%
CanAlaska Uranium Ltd.